citrulline has been researched along with vorinostat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, HB; Chong, W; Demoya, M; Fukudome, EY; Jin, G; King, DR; Li, Y; Liu, B; Liu, Z; Lu, J; Velmahos, GC | 1 |
Alam, HB; Chong, W; Li, Y; Liu, B; Liu, Z; Wang, Y; Zhao, T | 1 |
2 other study(ies) available for citrulline and vorinostat
Article | Year |
---|---|
Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock.
Topics: Animals; Biomarkers; Blotting, Western; Citrulline; Disease Models, Animal; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Random Allocation; Sensitivity and Specificity; Shock, Hemorrhagic; Survival Rate; Tumor Necrosis Factor-alpha; Vorinostat | 2011 |
Citrullinated histone H3: a novel target for the treatment of sepsis.
Topics: Animals; Antibodies, Neutralizing; Biomarkers; Citrulline; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Hydrolases; Hydroxamic Acids; Male; Mice; Mice, Inbred C57BL; Ornithine; Protein-Arginine Deiminase Type 4; Sepsis; Shock, Septic; Vorinostat | 2014 |